DELIVERING INNOVATION TO THE EYE Trademark

Trademark Overview

On Tuesday, November 29, 2016, a trademark application was filed for DELIVERING INNOVATION TO THE EYE with the United States Patent and Trademark Office. The USPTO has given the DELIVERING INNOVATION TO THE EYE trademark a serial number of 87250608. The federal status of this trademark filing is REGISTERED as of Tuesday, October 1, 2019. This trademark is owned by pSivida US, Inc.. The DELIVERING INNOVATION TO THE EYE trademark is filed in the Pharmaceutical Products and Medical Instrument Products categories with the following description:

Drug delivery agents consisting of polymer compounds that facilitate the delivery of pharmaceuticals for the treatment of ocular diseases and conditions, namely, uveitis and retinal disease

Sustained drug delivery systems for ocular drugs

General Information

Serial Number87250608
Word MarkDELIVERING INNOVATION TO THE EYE
Filing DateTuesday, November 29, 2016
Status700 - REGISTERED
Status DateTuesday, October 1, 2019
Registration Number5874660
Registration DateTuesday, October 1, 2019
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 18, 2017

Trademark Statements

Goods and ServicesDrug delivery agents consisting of polymer compounds that facilitate the delivery of pharmaceuticals for the treatment of ocular diseases and conditions, namely, uveitis and retinal disease
Goods and ServicesSustained drug delivery systems for ocular drugs

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, December 5, 2016
Primary Code005
First Use Anywhere DateFriday, May 10, 2019
First Use In Commerce DateFriday, May 10, 2019
International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateMonday, December 5, 2016
Primary Code010
First Use Anywhere DateFriday, May 10, 2019
First Use In Commerce DateFriday, May 10, 2019

Trademark Owner History

Party NameEYEPOINT PHARMACEUTICALS US, INC.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressWATERTOWN, MA 02472
Party NameEYEPOINT PHARMACEUTICALS US, INC.
Party Type21 - New Owner After Publication
Legal Entity Type03 - Corporation
AddressWATERTOWN, MA 02472
Party NamepSivida US, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressWatertown, MA 02472
Party NamepSivida US, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressWatertown, MA 02472

Trademark Events

Event DateEvent Description
Tuesday, April 18, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Friday, December 2, 2016NEW APPLICATION ENTERED
Monday, December 5, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, December 8, 2016TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, December 8, 2016ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, March 3, 2017ASSIGNED TO EXAMINER
Tuesday, March 7, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, March 29, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, April 18, 2017PUBLISHED FOR OPPOSITION
Saturday, May 12, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, June 13, 2017NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, September 4, 2017SOU TEAS EXTENSION RECEIVED
Monday, September 4, 2017SOU EXTENSION 1 FILED
Monday, September 4, 2017SOU EXTENSION 1 GRANTED
Wednesday, September 6, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, April 18, 2018AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Thursday, May 10, 2018SOU TEAS EXTENSION RECEIVED
Thursday, May 10, 2018SOU EXTENSION 2 FILED
Thursday, May 10, 2018SOU EXTENSION 2 GRANTED
Friday, June 7, 2019SOU TEAS EXTENSION RECEIVED
Friday, June 7, 2019SOU EXTENSION 4 FILED
Friday, June 7, 2019SOU EXTENSION 4 GRANTED
Friday, November 9, 2018SOU TEAS EXTENSION RECEIVED
Friday, November 9, 2018SOU EXTENSION 3 FILED
Friday, November 9, 2018SOU EXTENSION 3 GRANTED
Tuesday, November 13, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, June 11, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, July 15, 2019USE AMENDMENT FILED
Monday, July 15, 2019TEAS STATEMENT OF USE RECEIVED
Thursday, August 29, 2019ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Friday, August 30, 2019NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, October 1, 2019REGISTERED-PRINCIPAL REGISTER
Wednesday, October 28, 2020TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, October 28, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, August 6, 2019CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, August 6, 2019STATEMENT OF USE PROCESSING COMPLETE
Wednesday, October 28, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, October 28, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, October 28, 2020APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, October 1, 2024COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

Related Keywords

innovation delivering delivery drug ocular retinal uveitis namely disease sustained drugs systems